Delivery Order SPE2DB20D2001-SPE2DB25FPNME
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $48,915.64 to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 ml pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price, competitively awarded delivery order was issued with no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,990.49 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pens on July 31, 2025, with completion scheduled for August 1, 2025. This firm fixed-price, non-competitive delivery order represents a small-value pharmaceutical procurement executed under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $46,456.89 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens. This firm fixed-price, competitively awarded delivery order was issued on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's competitive standing...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Mounjaro 10 mg/0.5 ml pens in 0.5 ml doses. This firm fixed-price delivery order, valued at $2,720.90, represents a non-competitive award to the contractor's Conshohocken, Pennsylvania facility and is scheduled for completion by August 6, 2025. The order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $2,448.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units). The contract is scheduled for completion by September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,172.35 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors. This firm fixed-price delivery order, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a non-competitive, non-set-aside award. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $1,360.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pens (0.5 mL). The contract, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a non-set-aside competitive award. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,610.41 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pen (0.5 mL units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,360.45 for Mounjaro 15 mg/0.5 ml pen injectors on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors, with a contract ceiling value of $6,947.95. This competitively awarded, firm fixed-price delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order represents a...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB25FPNMEDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,340.37 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitively awarded order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $1 billion pharmaceutical supply vehicle valued through December 2026 that enables the distributor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs and maintains an extensive portfolio of federal contract awards predominantly with the DLA Medical Supply Chain. The company's capacity to fulfill this order for Mounjaro—a diabetes medication—reflects its established capability to deliver specialized pharmaceuticals across multiple therapeutic domains to support the Defense Health Agency and other government healthcare systems. This delivery order exemplifies the company's ongoing role as a key supplier within the DLA's pharmaceutical procurement strategy for military and federal medical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.3k | 8/18/25 |